40 Sites Across The Country To Test New Alzheimer's Drug [Forbes]
Biohaven Ltd. Common Shares (BHVN)
Last biohaven ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Forbes
40 Sites Across The Country To Test New Alzheimer's Drug The University of California, San Diego, through its Alzheimer's Disease Cooperative Study (ADCS) A progressive, fatal neurodegenerative dementia that accounts for 60 - 80 percent of dementia cases, AD is attacking the brains of an estimated 5.7 million people in the U.S., with those numbers expected to triple by 2050 without prevention or cure. Formed in 1991, the ADCS program is part of the National Institute on Aging (NIA) Division of Neuroscience’s effort to facilitate the discovery, development and testing of new drugs for the treatment of Alzheimer’s. Neurons. Getty T2 Protect AD www.T2Protect.org The T2 Protect AD study tests Biohaven’s new investigational drug called troriluzole “We are examining for benefits in cognitive function and thinking and memory over the course of one year,” said Howard Feldman, M.D. ontributions in scientific discoveries and clinical research studies focused on aging, mild cognitive impairment/
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Biohaven Ltd. (NYSE: BHVN) had its price target raised by analysts at UBS Group AG from $59.00 to $60.00. They now have a "buy" rating on the stock.MarketBeat
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]Yahoo! Finance
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesPR Newswire
- Biohaven Ltd. (NYSE: BHVN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Biohaven Announces Pricing of $230 Million Public Offering of Common Shares [Yahoo! Finance]Yahoo! Finance
BHVN
Earnings
- 11/14/23 - Miss
BHVN
Sec Filings
- 4/25/24 - Form 4
- 4/23/24 - Form 4
- 4/23/24 - Form 4
- BHVN's page on the SEC website